	Real-world clinical, biomarker, and imaging outcomes of lecanemab in Alzheimer's disease: a multicenter longitudinal cohort study in Jiangsu, China. Alzheimers Dement Tang L, Chen X, Zhang L, Fan L, Chen N, Li C, Cai Z, Chen G, Chen H, Ye M, Zheng H, Li Q, Ke Z, Hu Z, Cao M, Yang D, Xu S, Xie C, Li X, Xu X, Yu M, Lian X, Hu H, Li H, Cai X, Chen H, Xu W, Cui G, Zhao Y, Dong J, Zhang L, Zhu X, Zhao H, Xu Y. PMID: 42934846 [PubMed - indexed for MEDLINE]
	Advances in modified anti-AÎ² antibodies for the treatment of Alzheimer's disease. BMC Med Li S, Gu J, Xu Z, He C, Yu C. PMID: 42934641 [PubMed - indexed for MEDLINE]
	Spectrum of amyloid-related imaging abnormalities associated with aducanumab treatment: a case series report. BMC Neurol Atri A, Curiale GG, Aisen P, Barakos J, Purcell D, Bracoud L, Haeberlein SB, Grassi C, Hughes R, Smirnakis K. PMID: 42934592 [PubMed - indexed for MEDLINE]
	Serum neurofilament light protein as a biomarker across the cognitive decline continuum: a cross-sectional study from an Indian cohort. Aging Clin Exp Res Rao A, Anwar M, Rao AR, Painkra B, Kiruthika S, Kumar S, Yadav Y, Dey AB, Dey S, Chatterjee P. PMID: 42934374 [PubMed - indexed for MEDLINE]
	Histone Modifications at the Intersection of Aging, Neuroinflammation and Metabolism in Alzheimer's Disease. Aging Cell Liang J, Cao H, Ren X, Sha N, Han X, Jiang L, Liu B, Zhao W. PMID: 42934178 [PubMed - indexed for MEDLINE]
	Mechanisms of Traditional Chinese Medicine-Derived Active Components in the Treatment of Alzheimer's Disease: A Comprehensive Review. J Ethnopharmacol Tian Y, Guo J, Lin X, Zhang F, Xie J, Hou X, Deng J, Hao E, Du Z. PMID: 42933739 [PubMed - as supplied by publisher]
	Immunopharmacology of proton pump inhibitors in Alzheimer's Disease: An evidence-weighted mechanistic review of Neuroinflammation, neuroprotection, and neurodegeneration. Int Immunopharmacol Alshammari F, M Al-Kuraishy H, M Abdelaziz A, Alruwaili M, Batiha GE. PMID: 42933077 [PubMed - as supplied by publisher]
	Handwriting-based Alzheimer's disease classification on the DARWIN dataset: Repeated nested validation, task-level reduction, and cross-validated explainability. PLoS One Fatima T, Lashari TA, Moetesum M, Lashari SA. PMID: 42932271 [PubMed - indexed for MEDLINE]
	Early Diagnostic Classification of Alzheimer's Disease Using Structural and Resting-State Functional MRI. Neurol Int Liu J, Zhu B, Yu M, Du S. PMID: 42931145 [PubMed]
	INPP5D/SHIP1 in Alzheimer's Disease: Linking Microglial Substrate Handling to Neuroinflammation and Neurovascular Dysfunction. Neurol Int Xu J, Chang Y, Liu D, Chen C. PMID: 42931140 [PubMed]
	Therapeutic Potential of Marine Natural Products Against Alzheimer's Disease: Molecular Mechanisms, Druggability Evaluation and Clinical Translation Barriers. Mar Drugs Huang D, Lu R, Sheng C, Zheng J, Wang Y, Sang Z. PMID: 42930485 [PubMed - indexed for MEDLINE]
	Genetic Spectrum, Family History and Diagnostic Yield of Targeted Genetic Testing in Early-Onset Alzheimer's Disease and Frontotemporal Dementia: A Serbian Memory Clinic. Diseases Mandi, Kosti, Marjanovi, Novakovi, Aleksi, Stojkovi, Stefanova E. PMID: 42929986 [PubMed]
	Blood transcriptomic signatures of vascular risk in Alzheimer's disease. Alzheimers Dement Han SW, Park YH, Pyun JM, Hwang J, Park JS, Kim S, Nho K. PMID: 42928439 [PubMed - indexed for MEDLINE]
	Neuropathologic features of cognitively defined Alzheimer's disease subgroups in the Adult Changes in Thought study. Alzheimers Dement Latimer CS, Walker RL, Bogdani M, Keene CD, Nolan AL, Child DD, Mukherjee S, Choi SE, Lee ML, Nakano C, Ehrlich K, McEvoy LK, Crane PK. PMID: 42928437 [PubMed - indexed for MEDLINE]
	Developing a microsimulation model of Alzheimer's disease for the evaluation of disease modifying therapies. Eur J Epidemiol van der Veere PJ, Broulíková HM, Hoogland J, Handels R, Vijverberg EGB, van Harten AC, Teunissen CE, Barkhof F, van de Giessen E, van der Flier WM, Berkhof J. PMID: 42928321 [PubMed - as supplied by publisher]
	Evaluating the Impacts of Inflammatory Proteins on the Risk of Alzheimer's Disease. Mol Neurobiol Zhang Z, Cao H, Baranova A, Zhang F. PMID: 42928319 [PubMed - indexed for MEDLINE]
	Targeting insulin resistance with exercise mimetics: A potential therapeutic strategy for Alzheimer's disease. Exp Neurol Shi H, Ke Z, Wang B, Zhang X, Gui Y, Zhang H, Liang R. PMID: 42927826 [PubMed - as supplied by publisher]
	Astrocytic timekeepers and their influence on brain waste clearance in Alzheimer's disease. Neurobiol Sleep Circadian Rhythms Koenders CL, Chiu R, Medeiros-Furquim T, Bergink S. PMID: 42926851 [PubMed]
	Sex differences in genetic liability to modifiable Alzheimer's disease risk factors. medRxiv Sharma RU, Tolosa-Tort P, Okorie M, Chatterjee A, Jonson C, Yaffe K, Belloy ME, Andrews SJ, ADGC and HABS-HD Study team. PMID: 42926614 [PubMed]
	Implementing the National Alzheimer's Coordinating Center Uniform Data Set (v3) within the Diabetes Prevention Program Outcomes Study. Neuroepidemiology Doherty LK, Dechiario I, Sherif H, Bowers A, Martinez D, Sanchez D, Febres GJ, Carmichael O, Shah V, Nadkarni NK, Goldberg T, Noble J, Luchsinger JA, Temprosa M. PMID: 42925530 [PubMed - as supplied by publisher]

Articles 1 - 20 / 72885

Page 1 of 3645



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy